Showing 1 - 10 of 1,409
Persistent link: https://www.econbiz.de/10013040759
Persistent link: https://www.econbiz.de/10011508040
Persistent link: https://www.econbiz.de/10003743600
Persistent link: https://www.econbiz.de/10003782082
Persistent link: https://www.econbiz.de/10003834014
Persistent link: https://www.econbiz.de/10003996503
This paper studies interaction of pharmaceutical regulation and parallel trade in a North-South framework. An innovative Örm located in the North can sell its drug only in the North or in both countries. Governments may limit reimbursement for the drug. Reimbursement limits reduce the Örmís...
Persistent link: https://www.econbiz.de/10011290061
Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of...
Persistent link: https://www.econbiz.de/10010524004
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by parallel trade, i.e. trade outside the manufacturerś authorized distribution channel. In particular, maximum wholesale margins, a restriction of pricing by the intermediary, and...
Persistent link: https://www.econbiz.de/10010223101